Isolation and identification of neuroprotective compounds from Morus alba L. root bark against NMDA-induced retinal degeneration

Read full text Summarise with VIRAT
Authors: Tam Thi Le, Hai Yen Nguyen, Hyejin Ko, Hong Ryul Ahn, Trang Thi Thu Pham, Sungjae Yang, Sang Hoon Jung
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Morus alba L. root bark (MAR) has been used in traditional Chinese medicine and has recently attracted attention for its neuroprotective potential. In this study, 23 compounds were isolated from MAR, including two new compounds (1 and 2) and six new natural products (3–8) present as stereoisomeric mixtures, all characterised by NMR, ECD, and HRESIMS. Bioactivity screening identified five compounds (2, 9, 11, 18, and 19) with significant neuroprotective effects, with compound 19 (EC50 = 0.3 ± 0.12 µM) showing the strongest effect. Under glutamate-induced oxidative stress, compound 19 reduced ROS levels from 2.23-fold to near control levels (1.07-fold) and markedly decreased apoptosis. In an NMDA-induced retinal degeneration mouse model, compound 19 preserved retinal thickness, reduced retinal ganglion cell loss, and suppressed apoptosis-related protein expression. These results significantly expand the phytochemical profile of MAR and highlight compound 19 as a promising glaucoma therapeutic candidate.

Fields of Study & Subjects

Phytochemistry and Biological Activities Bioactive natural compounds Medicinal Plants and Neuroprotection

Publication details

Journal / source
Figshare
Publication date
28 March 2026
Language
EN